Fundamental dimension Equity attribute | HONPeer $209.98▼-0.68% Cap $66.55BP/E 8.1x QuantScore54/100 | GEPeer $286.69▼-2.33% Cap $297.5BP/E 32.9x QuantScore46/100 | HEILeader $298.96▼-0.35% Cap $41.65BP/E 49.2x QuantScore56/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical Trend, RSI, MACD & signal consensus | |||
57/100 |
31/100 |
46/100 |
Valuation Multiples, PEG & DCF upside | 98/100 | 39/100 | 32/100 |
Health Piotroski, Altman Z, leverage & liquidity | 23/100 | 46/100 | 77/100 |
Growth Revenue / earnings growth & margins | 14/100 | 49/100 | 64/100 |
Sentiment Analyst ratings, targets & revisions | 76/100 | 67/100 | 62/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 8.1x | 32.9x | 49.2x |
Forward P/E (next FY) | 25.3x | 35.3x | 47.2x |
EV / EBITDA (TTM) | 7.1x | 24.0x | 30.0x |
Price / Sales | 1.8x | 5.7x | 8.0x |
Price / Free Cash Flow | 16.2x | 37.1x | 40.4x |
PEG ratio | 0.18 | 2.10 | 1.56 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 7 / 9 | 6 / 9 |
Altman Z-Score | 2.74 (Grey) | 3.37 (Safe) | 7.55 (Safe) |
Total debt / equity | 1.83 | 1.10 | 0.51 |
Quick ratio | 0.9x | 0.7x | 1.3x |
Interest coverage | 3.5x | 10.9x | 9.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +7.8% | +18.5% | +16.3% |
Net income growth YoY | -17.1% | +32.8% | +34.3% |
Gross margin (TTM) | 36.6% | 35.2% | 40.4% |
Operating margin (FY) | 17.5% | 19.1% | 22.7% |
FCF margin (FY) | 14.5% | 15.8% | 19.2% |
5. Trailing price performancePrice change over period |
1M return | +1.7% | -10.7% | -4.3% |
3M return | -6.7% | -19.2% | -12.7% |
6M return | -14.3% | +0.4% | +10.6% |
Year to date | +2.6% | -7.3% | -8.1% |
1Y return | +3.1% | -6.0% | -6.4% |
3Y return | +16.5% | +215.2% | +89.2% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $450.03 +114.3% upside | $59.37 -79.3% premium | $118.37 -60.4% premium |
Wall Street consensus target | $258.92 +23.3% · range $231.00–$293.00 | $385.71 +34.5% · range $350.00–$435.00 | $394.78 +32.1% · range $345.00–$491.00 |
Consensus stance | 67% Buy33% Hold0% Sell | 67% Buy31% Hold3% Sell | 61% Buy39% Hold-0% Sell |